Gemifloxacin Mesylate Patent Expiration
Gemifloxacin Mesylate is used for treating various bacterial infections. It was first introduced by Lg Chem Ltd
Gemifloxacin Mesylate Patents
Given below is the list of patents protecting Gemifloxacin Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Factive | US6262071 | Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria |
Sep 21, 2019
(Expired) | Lg Chem Ltd |
| Factive | US6331550 | Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
Sep 21, 2019
(Expired) | Lg Chem Ltd |
| Factive | US6455540 | Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
Sep 21, 2019
(Expired) | Lg Chem Ltd |
| Factive | US6803376 | Method of use of quinolone compounds against pneumococcal and haemophilus bacteria |
Sep 21, 2019
(Expired) | Lg Chem Ltd |
| Factive | US6340689 | Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria |
Sep 14, 2019
(Expired) | Lg Chem Ltd |
| Factive | US6723734 | Salt of naphthyridine carboxylic acid derivative |
Mar 20, 2018
(Expired) | Lg Chem Ltd |
| Factive | US5776944 | 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
Apr 04, 2017
(Expired) | Lg Chem Ltd |
| Factive | US5633262 | Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
Jun 15, 2015
(Expired) | Lg Chem Ltd |
| Factive | US5962468 | 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
Jun 15, 2015
(Expired) | Lg Chem Ltd |
Gemifloxacin Mesylate's Family Patents
Explore Our Curated Drug Screens
Gemifloxacin Mesylate Generic API Manufacturers
Only one generic application has been filed for Gemifloxacin Mesylate.
Given below is the list of companies who have filed for Gemifloxacin Mesylate generic, along with the locations of their manufacturing plants worldwide.
1. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 1 generic for Gemifloxacin Mesylate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 320MG BASE | tablet | Discontinued | ORAL | N/A | Jun 15, 2015 |